MGMT and glioblastoma: Temozolomide, an alkylating agent, is a critical component of chemotherapy regimens for glioblastoma and works by promoting methylation of O6-methylguanine-DNA methyltransferase (MGMT), a DNA repair enzyme associated with treatment resistance [13].